SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 84.48 |
Enterprise Value ($M) | 86.16 |
Book Value ($M) | 8.90 |
Book Value / Share | 0.56 |
Price / Book | 9.49 |
NCAV ($M) | 1.70 |
NCAV / Share | 0.11 |
Price / NCAV | 49.84 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.47 |
Return on Assets (ROA) | -2.09 |
Return on Equity (ROE) | -10.53 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.83 |
Current Ratio | 1.83 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 20.93 |
Assets | 28.14 |
Liabilities | 19.24 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -44.99 |
Net Income | -51.90 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -37.07 |
Cash from Investing | -0.08 |
Cash from Financing | 42.32 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Actyus Private Equity SGIIC, S.A. | 5.40 | 45.69 | |
13D/A | Yekaterina Chudnovsky | 48.10 | ||
13G | Knoll Capital Management, LLC | 5.20 | ||
13D/A | Gkcc, Llc | 38.70 | 159.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
786 | 7,205 | 10.91 | |
8,894 | 33,010 | 26.94 | |
1,216 | 14,721 | 8.26 | |
3,583 | 6,723 | 53.29 | |
(click for more detail) |
Similar Companies | |
---|---|
EDSA – Edesa Biotech, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
ELEV – Elevation Oncology, Inc. | ELUT – Elutia Inc. |
ENLV – Enlivex Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io